ResearcherScripps Research InstituteActive in the last 2 years

Chi‐Huey Wong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8225-6808; OpenAlex author ID A5101786683. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade. Last author DOI 10.1073/pnas.2517415122 ↗
Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer. Last author DOI 10.1073/pnas.2114774118 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Po‐Kai Chuang · 1 shared paper, 2025 · strength 0.37
- Paper Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune che… DOI 10.1073/pnas.2517415122 ↗
Chih-Wei Lin · 1 shared paper, 2021 · strength 0.12
- Paper Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer. DOI 10.1073/pnas.2114774118 ↗
Chia‐Ning Shen · 1 shared paper, 2021 · strength 0.12
- Paper Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer. DOI 10.1073/pnas.2114774118 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.